Key Publications

Small AG, Thwe LM, Byrne JA, Lau L, Chan A, Craig ME, Cowell CT, Garnett SP (2015) Neuroblastoma, body mass index and survival: a retrospective analysis. Medicine (Baltimore) 94(14):e713

Farooqi AS, Dagg RA, Choi LMR, Shay JW, Reynolds CP, Lau LMS (2014). Alternative lengthening of telomeres in neuroblastoma cell lines is associated with a lack of MYCN genomic amplification and with p53 pathway aberrations. J Neuro-Oncology 119(1):17-26

Lee M, Hills M, Conomos D, Stutz, MD, Dagg, RA, Lau LM, Reddel RR, Pickett HA (2014) Telomere extension by telomerase and ALT generates variant repeats by mechanistically distinct processes. Nucleic Acids Research 42(30): 1733-46

Saletta F, Seng MS, Lau LMS (2014). Advances in paediatric cancer treatment. Translational Paediatrics 3(2):156-182

Lau LM, Dagg RA, Henson JD, Au AY, Royds JA, Reddel RR (2013) Detection of alternative lengthening of telomeres by telomere quantitative PCR. Nucleic Acids Research 41(2):e34

Bower K, Napier CE, Cole SL, Dagg RA, Lau LMS, Duncan EL, Moy EL, Reddel RR (2012) Loss of wild-type ATRX expression in somatic cell hybrids segregates with activation of Alternative Lengthening of Telomeres. PLoS ONE 7(11):e50062

Lau LMS, London WB (2012) Recurrent Neuroblastoma. In: Shimada H, editor. Neuroblastoma – Present and Future, InTech Open Access Publisher

Lau LMS, Irwin MS (2010) Molecular Pathogenesis of Neuroblastomas (Chapter 25). In: Mehta MP, Chang SM, Vogelbaum MA, Guha A, editors; Principles and Practices of Neuro-Oncology: A Multidisciplinary Approach. New York: Demos Medical Publishing